Deerfield Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $25M | Sell |
|
|||||
|
2021
Q2 | $27.5M | Hold |
|
|||||
|
2021
Q1 | $29.8M | Sell |
|
|||||
|
2020
Q4 | $53.9M | Hold |
|
|||||
|
2020
Q3 | $47.4M | Hold |
|
|||||
|
2020
Q2 | $40.2M | Buy |
|
|||||
|
2020
Q1 | $30.8M | Sell |
|
|||||
|
2019
Q4 | $72.6M | Buy |
|
|||||
|
2019
Q3 | $51.6M | Hold |
|
|||||
|
2019
Q2 | $53.6M | Buy |
|
|||||
|
2019
Q1 | $58.5M | Sell |
|
|||||
|
2018
Q4 | $60.4M | Buy |
|
|||||
|
2018
Q3 | $64M | Sell |
|
|||||
|
2018
Q2 | $54.7M | Buy |
|
|||||
|
2018
Q1 | $24M | Hold |
|
|||||
|
2017
Q4 | $26.1M | Hold |
|
|||||
|
2017
Q3 | $23M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $9.33M | Buy |
|
|||||
|
2015
Q4 | $10.4M | Buy |
|